as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.33%
Downside
5.11%
Upside
52 Week's Low
52 Week's High
42.83%
Downside
-5.21%
Upside
Check Roivant Sciences Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.5B
EPS (TTM)
-0.57
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
1.88
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-1.1B
Revenue (TTM)
23.2M
Profit Margin
0.00%
Return On Equity TTM
85578200.00%
Track how Roivant Sciences Ltd. P/E has moved over time to understand its valuation trends.
Roivant Sciences Ltd. in the last 5 years
Lowest (0.00x)
September 17, 2025
Today (1.88x)
September 17, 2025
Industry (10.13x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: 1.88x
Compare market cap, revenue, PE, and other key metrics of Roivant Sciences Ltd. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.5B | NA | 1.88 | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Roivant Sciences Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Roivant Sciences Ltd. investment value today
Current value as on today
₹1,31,320
Returns
₹31,320
(+31.32%)
Returns from Roivant Sciences Ltd. Stock
₹26,722 (+26.72%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 17 analysts
88.24%
Buy
11.76%
Hold
0.00%
Sell
Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Roivant Sciences Ltd.. Average target price of $17.1
Get share price movements and forecasts by analysts on Roivant Sciences Ltd..
What analysts predicted
10.7%UPSIDE
Target Price
$17.1
Current Price
$15.27
Analyzed by
17 Analysts
Target
$17.10
Roivant Sciences Ltd. target price $17.1, a slight upside of 10.7% compared to current price of $15.27. According to 17 analysts rating.
Search interest for Roivant Sciences Ltd. Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 September
Wed, 09:30 PM
-Roivant Sciences stock rises 11% after positive Phase 3 trial results for brepocitinib in treating dermatomyositis.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, ROIV stock has moved up by 20.1%
Best in 3 Years
In the last 3 years, ROIV has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 50.7%
Profit Down
Netprofit is down for the last 3 quarters, 169.38M → -223.35M (in $), with an average decrease of 115.0% per quarter
Revenue Fall
Revenue is down for the last 3 quarters, 9.01M → 2.17M (in $), with an average decrease of 43.7% per quarter
Organisation | Roivant Sciences Ltd. |
Headquarters | 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB |
Industry | Financial |
CEO | Mr. Matthew Gline |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Matthew Gline | CEO & Director |
Dr. Huafeng Xu Ph.D. | Chief Technology Officer |
Mr. Drew Kramer | Chief Information Officer |
Ms. Kelly Graff | Head of People |
Dr. Eric Venker M.D., Pharm.D. | President & CEO of Immunovant |
Dr. Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director |
Mr. Richard Pulik | Chief Financial Officer |
Ms. Jennifer Humes | Chief Accounting Officer |
Dr. Frank M. Torti M.B.A., M.D. | President & Vant Chair |
Mr. Josh Chen J.D. | General Counsel |
Roivant Sciences Ltd. share price today is $15.27 as on at the close of the market. Roivant Sciences Ltd. share today touched a day high of $16.05 and a low of $15.22.
Roivant Sciences Ltd. share touched a 52 week high of $14.48 on and a 52 week low of $8.73 on . Roivant Sciences Ltd. stock price today i.e. is closed at $15.27,which is -5.49% down from its 52 week high and 74.91% up from its 52 week low.
Roivant Sciences Ltd. market capitalisation is $0.01T as on .
Indian investors can start investing in Roivant Sciences Ltd. (ROIV) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Roivant Sciences Ltd. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Roivant Sciences Ltd. share’s latest price of $15.27 as on September 18, 2025 at 1:29 am IST, you will get 0.6549 shares of Roivant Sciences Ltd.. Learn more about
fractional shares .